You searched for obesity | Page 12 of 30

Study Reveals the Hidden Pandemic of Fatty Liver Disease

New research creates a road map for future treatments of nonalcoholic fatty liver disease and confirms the need for more mainstream screening.

Testing for, monitoring, and controlling diabetes continues to become more robust, cost-effective, and nuanced.

Siemens Healthineers’ Enhanced Liver Fibrosis (ELF) Test was granted marketing authorization under the De Novo review pathway.

Researchers have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.

Posted by Laurie Bonner | Mar 26, 2021 | Disease States |

Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.